Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Argenx Se ADR LAARDERHOOGTWEG 25 AMSTERDAM P7 1101EB NLD

www.argenx.com P: 31-10-703-8441

Description:

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 21,906,262
Enterprise Value, $K 19,857,422
Shares Outstanding, K 59,431
Annual Sales, $ 1,269 M
Annual Net Income, $ -295,050 K
Last Quarter Sales, $ 417,960 K
Last Quarter Net Income, $ -99,170 K
EBIT, $ -425,040 K
EBITDA, $ -313,730 K
60-Month Beta 0.65
% of Insider Shareholders 2.43%
% of Institutional Shareholders 60.32%
Float, K 57,987
% Float 97.57%
Short Volume Ratio 0.30

Growth:

1-Year Return -5.61%
3-Year Return 28.56%
5-Year Return 190.49%
5-Year Revenue Growth 3,574.94%
5-Year Earnings Growth -119.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.68 on 02/29/24
Latest Earnings Date 05/02/24 [--]
Earnings Per Share ttm -5.14
EPS Growth vs. Prev Qtr -34.40%
EPS Growth vs. Prev Year -140.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ARGX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.97%
Return-on-Assets % -15.26%
Profit Margin % -23.26%
Debt/Equity 0.00
Price/Sales 17.57
Price/Cash Flow N/A
Price/Book 5.33
Book Value/Share 69.23
Interest Coverage -333.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar